Search company, investor...

BioMedical Enterprises

Founded Year



Acquired | Acquired

Total Raised


About BioMedical Enterprises

BioMedical Enterprises is a maker of nickel-titanium alloy implants that are used to help small bones heal.

Headquarters Location

14785 Omicron Dr Suite 205

San Antonio, Texas, 78245,

United States


Missing: BioMedical Enterprises's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: BioMedical Enterprises's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing BioMedical Enterprises

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

BioMedical Enterprises is included in 2 Expert Collections, including Medical Devices.


Medical Devices

8,537 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

BioMedical Enterprises Patents

BioMedical Enterprises has filed 1 patent.

The 3 most popular patent topics include:

  • Implants (medicine)
  • Orthopedic surgical procedures
  • Prosthetics
patents chart

Application Date

Grant Date


Related Topics




Orthopedic surgical procedures, Implants (medicine), Medical equipment manufacturers, Drilling technology, Surgical removal procedures


Application Date


Grant Date



Related Topics

Orthopedic surgical procedures, Implants (medicine), Medical equipment manufacturers, Drilling technology, Surgical removal procedures



Latest BioMedical Enterprises News

Texas Roundup: Adhesys, Emily Keeton, BioMedical Enterprises & Vyopta

May 16, 2016

Reprints Let’s get caught up with the latest innovation news at Xconomy Texas. —Station Houston co-founder Emily Keeton was the featured speaker at Startup Grind Houston’s most recent fireside chat event. Keeton became the national president of Lemonade Day, an organization that supports entrepreneurship in kids, and spoke specifically about encouraging young women in innovation. —The University of Texas System is collecting anonymous patient and administrative data from its hospitals around the state to build a data analytics network . The information will be used to analyze and assess improvements to patient care. UT’s board of regents approved $12.4 million to pay for the network. —Houston’s Adhesys Medical has formed a partnership with a German pharmaceutical company to market its surgical adhesive in Latin America and Europe. Adhesys makes an adhesive “glue” that can be spread on the skin or internally in the body, on organs, in order to seal wounds. The company won the Rice University Business Plan Competition in 2014. —A San Antonio, TX, maker of nickel-titanium alloy implants has been acquired by a Johnson & Johnson subsidiary. DePuy Synthes purchased BioMedical Enterprises, which makes implants out of Nitinol. DePuy said Nitinol provides “dynamic continuous active compression,” which helps bone healing. —Vyopta, an Austin company that makes a video conferencing system dashboard for businesses, picked up an additional $1 million in funding. The company had originally announced in February that it has raised $5 million. AVX Partners, Vyopta’s investor in the original round, put up the additional $1 million. Angela Shah is the editor of Xconomy Texas. She can be reached at or (214) 793-5763. Follow @angelashah

BioMedical Enterprises Frequently Asked Questions (FAQ)

  • When was BioMedical Enterprises founded?

    BioMedical Enterprises was founded in 1991.

  • Where is BioMedical Enterprises's headquarters?

    BioMedical Enterprises's headquarters is located at 14785 Omicron Dr, San Antonio.

  • What is BioMedical Enterprises's latest funding round?

    BioMedical Enterprises's latest funding round is Acquired.

  • How much did BioMedical Enterprises raise?

    BioMedical Enterprises raised a total of $7.2M.

  • Who are the investors of BioMedical Enterprises?

    Investors of BioMedical Enterprises include Johnson & Johnson, Cross Atlantic Capital Partners, Camden Partners, Akin Gump Strauss Hauer & Feld, Cross Atlantic Partners and 3 more.

  • Who are BioMedical Enterprises's competitors?

    Competitors of BioMedical Enterprises include Noraker, Spine Wave, Microfabrica, Expanding Orthopedics, Spinal Kinetics and 13 more.

Compare BioMedical Enterprises to Competitors

Doctors Research Group

Doctors Research Group focuses on producing and marketing medical products. Currently, they are focusing on the development of a new type of bone cement or bone glue called Kryptonite.


Biorthex is an orthopedic device manufacturer that develops manufactures and markets innovative spinal interbody fusion devices and instruments for the treatment of degenerative conditions of the human spine

Theken Disc

Theken Disc, LLC founded in 2003 designs, develops and manufactures spinal arthroplasty products, such as the eDisc, a microelectronic artificial spinal disc replacement.

Simpirica Spine

Simpirica is developing a dynamic stabilization system designed to stabilize the spine in flexion and help patients return to more healthy, active lifestyles. The company's lead product, the LimiFlex Spinal Stabilization System, is typically used in conjunction with a surgical decompression for the treatment of lumbar spinal stenosis with or without degenerative spondylolisthesis.

Axial Biotech

Axial Biotech, founded in 2002 by a group of spine surgeons and geneticists, is focused on the use of genetics and the development of minimally invasive fusionless devices to advance the diagnosis and treatment of diseases and deformities of the human spine. Axial is a company to pursue DNA-based pre-symptomatic and prognostic tests for common spinal conditions which will augment current clinical and surgical practices. In its initial genetic product development initiative, Axial has made progress towards the discovery of a location in the human genome that is associated with adolescent idiopathic scoliosis. In addition, Axial's founders have developed five motion preserving, fusionless surgical devices (including such device currently being implanted in humans) that have the promise of expanding the current treatable scoliosis patient population by a factor of ten. Axial intends to use its genetic intellectual property in the development of bio-mechanical devices, and to apply its gene discovery/product development methodology to other spinal diseases. Axial ( is located in Salt Lake City, Utah.


Kyphon develops and markets medical devices designed to restore spinal function using minimally invasive technologies. The company's KyphX(R) line of products is used in balloon kyphoplasty, a minimally invasive procedure to treat spinal fractures caused by osteoporosis or cancer. More information about the company can be found at

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.